Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:CE 21:4)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003913 AN006425 Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting Blood Human MaineHealth Institute for Research LC-MS/MS(Dir. Inf.)
ST003913 AN006425 Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting Bone marrow serum Human MaineHealth Institute for Research LC-MS/MS(Dir. Inf.)
ST001269 AN002109 Exosomal lipids for classifying early and late stage non-small cell lung cancer Blood Human Cancer University of Kentucky MS(Dir. Inf.)
ST000114 AN000192 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo